Cas:1202864-78-5 1-(2,2-dimethoxyethyl)-2-methoxybenzene manufacturer & supplier

Chemical Name:1-(2,2-dimethoxyethyl)-2-methoxybenzene

CAS.NO:1202864-78-5

Synonyms:2-Methoxyphenylacetaldehyde dimethylacetal

Molecular Formula:C₁₁H₁₆O₃

Molecular Weight:196.24300

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:27.69000

Exact Mass:196.11000

LogP:1.85660

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 2-Methoxyphenylacetaldehyde dimethylacetal chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Methoxyphenylacetaldehyde dimethylacetal physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methoxyphenylacetaldehyde dimethylacetal Use and application,2-Methoxyphenylacetaldehyde dimethylacetal technical grade,usp/ep/jp grade.

Related News: As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. 1-(2,2-dimethoxyethyl)-2-methoxybenzene manufacturer The KCDC said a 28-year-old man had tested positive. He was among the 368 repatriated South Koreans who arrived from Wuhan on a charter flight on January 31. The rest of the evacuees have tested negative for the coronavirus. 1-(2,2-dimethoxyethyl)-2-methoxybenzene supplier The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application. 1-(2,2-dimethoxyethyl)-2-methoxybenzene vendor It has contracted with the Chinese manufacturer Xiamen Biotime Biotechnology to produce the tests for international distribution. According to Innova, Biotime previously submitted performance data to the agency without seeking an EUA, while the company later presented equivalent data for the same test under the Innova brand. 1-(2,2-dimethoxyethyl)-2-methoxybenzene factory As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment.